Alternol, a natural compound, exerts an anti‐tumour effect on osteosarcoma by modulating of STAT 3 and ROS / MAPK signalling pathways-Reference-Cited by-同舟云学术

Alternol, a natural compound, exerts an anti‐tumour effect on osteosarcoma by modulating of STAT 3 and ROS / MAPK signalling pathways

Published:2016-09-14 Issue:2 Volume:21 Page:208-221
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Zuo Dongqing¹²,Zhou Zifei²³,Wang Hongsheng²⁴,Zhang Tao²,Zang Jie⁵,Yin Fei²,Sun Wei²,Chen Jiepeng⁶,Duan Lili⁶,Xu Jing²,Wang Zhuoying²,Wang Chongren²,Lin Binhui²,Fu Zeze²,Liao Yuxin¹,Li Suoyuan²,Sun Mengxiong²,Hua Yingqi²,Zheng Longpo¹,Cai Zhengdong²

Affiliation:

1. Department of Orthopedics Shanghai Tenth People's Hospital School of Medicine Tongji University Shanghai China

2. Department of Orthopaedics Shanghai First People's Hospital Shanghai Jiao Tong University Shanghai China

3. Department of Orthopaedics Shanghai East Hospital School of Medicine Tongji University Shanghai China

4. Department of Orthopaedics Yangpu Hospital School of Medicine Tongji University Shanghai China

5. Musculoskeletal Tumor Center People's Hospital Peking University Beijing China

6. Strand Biotechnology Institute of Research Shantou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.12957

Reference37 articles.

1. Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

2. Translational biology of osteosarcoma

3. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial

4. Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial

5. A systematic review of the clinical effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index in vivo;Frontiers in Pharmacology;2024-05-24

2. Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death;Frontiers in Pharmacology;2024-05-20

3. N-Acetyl-L-Cysteine Ameliorates BPAF-Induced Porcine Sertoli Cell Apoptosis and Cell Cycle Arrest via Inhibiting the ROS Level;Toxics;2023-11-11

4. Puerarin: A review of its mechanisms of action and clinical studies in ophthalmology;Phytomedicine;2022-12

5. Inhibiting STAT3 signaling pathway by natural products for cancer prevention and therapy: In vitro and in vivo activity and mechanisms of action;Pharmacological Research;2022-08